SCHEMBL29495231

SCHEMBL29495231

O=C(O)c1nc(-c2cncs2)cc2cn[nH]c12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CD38 P28907 6/20 0.54
▸ MYC P01106 1/20 0.35
▸ PIM1 P11309 2/20 0.34
▸ RXRA P19793 1/20 0.32
▸ RXRB P28702 1/20 0.32
▸ RXRG P48443 1/20 0.32
▸ PRMT5 O14744 1/20 0.31
▸ WDR77 Q9BQA1 1/20 0.31
▸ METAP2 P50579 3/20 0.31
▸ AR P10275 1/20 0.30
▸ PLK4 O00444 1/20 0.30
▸ CHEK1 O14757 1/20 0.30
▸ AURKA O14965 1/20 0.30
▸ DAPK3 O43293 1/20 0.30
▸ MAP4K4 O95819 1/20 0.30
▸ CSF1R P07333 1/20 0.30
▸ RET P07949 1/20 0.30
▸ FGFR1 P11362 1/20 0.30
▸ PDGFRA P16234 1/20 0.30
▸ LTK P29376 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29696530 0.88 CD38 (0.53) CD38MYCPIM1PRMT5WDR77
SCHEMBL28722328 0.82 CD38 (0.58) CD38METAP2
SCHEMBL29495195 0.80 CD38 (0.38) CD38MYCPIM1ARCHEK1
SCHEMBL22933528 0.78 CD38 (0.72) CD38
SCHEMBL29495260 0.77 CD38 (0.54) CD38MYCPIM1AR
SCHEMBL28722333 0.77 CD38 (0.43) CD38MYCPIM1PRMT5WDR77
SCHEMBL22933527 0.72 CD38 (1.00) CD38
SCHEMBL22715810 0.70 NOS1 (0.37) CD38RXRARXRBRXRGPLK4
SCHEMBL11907398 0.69 MAP2K3 (0.42) CD38MYCPIM1CHEK1
SCHEMBL28722672 0.69 CD38 (0.60) CD38METAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119431323-A Heterobicyclic amides as CD38 inhibitors 贝林格尔·英格海姆国际有限公司 2025-02-14 — — CN disclosed
CN-114423753-B Heterobicyclic amides as CD38 inhibitors 里邦医疗公司 2024-09-17 — — CN disclosed
EP-4003980-A1 HETEROBICYCLIC AMIDES AS INHIBITORS OF CD38 Ribon Therapeutics Inc. (US) 2022-06-01 — — EP disclosed
CN-114423753-A Heterobicyclic amides as CD38 inhibitors 里邦医疗公司 2022-04-29 — — CN disclosed
Send feedback